Cancer has been traditionally considered a genetic disease, involving a series of mutations that activate oncogenes and inactivate tumor suppressors.
1 x 1 Hanahan, D. and Weinberg, R.A. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646–674 Abstract | Full Text | Full Text PDF | PubMed | Scopus (23011) | Google Scholar See all References Although mutagenic events are critical for carcinogenesis, recent work has unequivocally demonstrated that cancer is also characterized by dysregulation of chromatin structure that involves the DNA itself (eg, CpG methylation) and its associated histones.
2 x 2 Baylin, S.B. and Jones, P.A. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11: 726–734 Crossref | PubMed | Scopus (1404) | Google Scholar See all References Because these epigenetic modifications are at least partially responsible for influencing tumorigenic processes, it is not surprising that several studies have demonstrated that prognosis of certain tumors can be predicted from analysis of epigenetic features.
3 x 3 Figueroa, M.E., Lugthart, S., Li, Y., Erpelinck-Verschueren, C., Deng, X., Christos, P.J., Schifano, E., Booth, J., van Putten, W., Skrabanek, L., Campagne, F., Mazumdar, M., Greally, J.M., Valk, P.J., Lowenberg, B., Delwel, R., and Melnick, A. DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell. 2010; 17: 13–27 Abstract | Full Text | Full Text PDF | PubMed | Scopus (498) | Google Scholar See all References
, 4 x 4 Noushmehr, H., Weisenberger, D.J., Diefes, K., Phillips, H.S., Pujara, K., Berman, B.P., Pan, F., Pelloski, C.E., Sulman, E.P., Bhat, K.P., Verhaak, R.G., Hoadley, K.A., Hayes, D.N., Perou, C.M., Schmidt, H.K., Ding, L., Wilson, R.K., Van Den Berg, D., Shen, H., Bengtsson, H., Neuvial, P., Cope, L.M., Buckley, J., Herman, J.G., Baylin, S.B., Laird, P.W., Aldape, K., and Cancer Genome Atlas Research Network. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 2010; 17: 510–522 Abstract | Full Text | Full Text PDF | PubMed | Scopus (1290) | Google Scholar See all References
, 5 x 5 Portela, A. and Esteller, M. Epigenetic modifications and human disease. Nat Biotechnol. 2010; 28: 1057–1068 Crossref | PubMed | Scopus (1284) | Google Scholar See all References